FOLFIRI chemotherapy for metastatic colorectal cancer patients
Objectives: 1) To confirm the efficacy of irinotecan plus folinic acid/continuous 5-fluorouracil as bimonthly FOLFIRI regimen in metastatic colorectal cancer patients. Efficacy evaluations will include response rate, duration of response, and survival. 2) To evaluate safety profiles on patients rece...
Saved in:
Main Authors: | Kamnerdsupaphon P., Lorvidhaya V., Chitapanarux I., Tonusin A., Sukthomya V. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-35848959497&partnerID=40&md5=c00a2c1fe2bf594897777d95f4e77f39 http://www.ncbi.nlm.nih.gov/pubmed/18041432 http://cmuir.cmu.ac.th/handle/6653943832/2127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
FOLFIRI chemotherapy for metastatic colorectal cancer patients
by: Pimkhuan Kamnerdsupaphon, et al.
Published: (2018) -
Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer
by: Chitapanarux I., et al.
Published: (2014) -
The study of cisplatin and vinorelbine in metastatic uterine cervical cancer
by: Kamnerdsupaphon P., et al.
Published: (2014) -
The study of cisplatin and vinorelbine in metastatic uterine cervical cancer
by: Pimkhuan Kamnerdsupaphon, et al.
Published: (2018) -
The study of cisplatin and vinorelbine in metastatic uterine cervical cancer
by: Pimkhuan Kamnerdsupaphon, et al.
Published: (2018)